Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treatment failure in AML.

H D Preisler

    Blood Cells
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Treatment failures in acute myelocytic leukemia (AML) are often overlooked. This study examines why remission induction fails and relapse occurs, considering patient factors and leukemia cell characteristics.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The effects of the farnesyl transferase inhibitor FTI L-778,123 on normal, myelodysplastic, and myeloid leukemia bone marrow progenitor proliferation in vitro.

    Leukemia & lymphoma·2003
    Same author

    Abnormalities of molecular regulators of proliferation and apoptosis in carcinoma of the oral cavity and oropharynx.

    Auris, nasus, larynx·2002
    Same author

    Evolution of secondary hematologic disorders: preMDS-->MDS-->sAML.

    Cancer treatment and research·2001
    Same author

    Special clinical concerns/problems in the management of MDS and secondary acute myeloid leukemias.

    Cancer treatment and research·2001
    Same author

    P15INK4B gene methylation and expression in normal, myelodysplastic, and acute myelogenous leukemia cells and in the marrow cells of cured lymphoma patients.

    Leukemia·2001
    Same author

    Alterations in IRF1/IRF2 expression in acute myelogenous leukemia.

    American journal of hematology·2001

    Area of Science:

    • Hematology
    • Oncology
    • Leukemia Research

    Background:

    • Successful acute myelocytic leukemia (AML) treatments often overshadow challenges.
    • Understanding treatment failures is crucial for improving patient outcomes.

    Purpose of the Study:

    • To analyze the reasons behind treatment failures in acute myelocytic leukemia (AML).
    • To investigate factors contributing to remission induction failure and leukemia relapse.

    Main Methods:

    • Literature review focusing on AML treatment outcomes.
    • Analysis of patient-related factors influencing therapy success.
    • Examination of leukemic cell heterogeneity in relation to treatment resistance.

    Main Results:

    Related Experiment Videos

  • Treatment failures in AML stem from both patient-specific issues and intrinsic leukemia cell properties.
  • Heterogeneity of leukemic cells presents a significant challenge to effective therapy.
  • Patient-related factors can impact the success of remission induction and the likelihood of relapse.

    • Conclusions:

    • Addressing patient-related factors and understanding leukemia cell heterogeneity are key to overcoming AML treatment failures.
    • Further research into personalized treatment strategies is warranted.
    • Improving remission induction rates and preventing relapse requires a multifaceted approach.